Global Fibrous Demineralized Bone Matrix (DBM) Market Growth 2024-2030

Global Fibrous Demineralized Bone Matrix (DBM) Market Growth 2024-2030

Demineralized Bone Matrix (DBM) is a bone grafting material that is processed from human or animal bone. The demineralization process involves removing the mineral content (mainly calcium) from the bone, leaving behind the organic matrix. This demineralization is typically done to make the bone more osteoconductive, meaning it promotes the ingrowth of new bone tissue.

The global Fibrous Demineralized Bone Matrix (DBM) market size is projected to grow from US$ 536.1 million in 2023 to US$ 702.7 million in 2030; it is expected to grow at a CAGR of 3.9% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Fibrous Demineralized Bone Matrix (DBM) Industry Forecast” looks at past sales and reviews total world Fibrous Demineralized Bone Matrix (DBM) sales in 2023, providing a comprehensive analysis by region and market sector of projected Fibrous Demineralized Bone Matrix (DBM) sales for 2024 through 2030. With Fibrous Demineralized Bone Matrix (DBM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fibrous Demineralized Bone Matrix (DBM) industry.

This Insight Report provides a comprehensive analysis of the global Fibrous Demineralized Bone Matrix (DBM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fibrous Demineralized Bone Matrix (DBM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fibrous Demineralized Bone Matrix (DBM) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fibrous Demineralized Bone Matrix (DBM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fibrous Demineralized Bone Matrix (DBM).

United States market for Fibrous Demineralized Bone Matrix (DBM) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Fibrous Demineralized Bone Matrix (DBM) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Fibrous Demineralized Bone Matrix (DBM) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Fibrous Demineralized Bone Matrix (DBM) players cover Medtronic, J &J (DePuy Synthes), Zimmer Biomet, Stryker and SeaSpine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Fibrous Demineralized Bone Matrix (DBM) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Gel
Putty
Others

Segmentation by application
Dental Surgery
Spine Surgery
Trauma Surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
J &J (DePuy Synthes)
Zimmer Biomet
Stryker
SeaSpine
Wright Medical
Straumann
Xtant Medical
Hans Biomed
Arthrex
VIVEX Biologics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fibrous Demineralized Bone Matrix (DBM) market?

What factors are driving Fibrous Demineralized Bone Matrix (DBM) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fibrous Demineralized Bone Matrix (DBM) market opportunities vary by end market size?

How does Fibrous Demineralized Bone Matrix (DBM) break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.